Your browser doesn't support javascript.
loading
The mechanistic target of rapamycin pathway downregulates bone morphogenetic protein signaling to promote oligodendrocyte differentiation.
Ornelas, Isis M; Khandker, Luipa; Wahl, Stacey E; Hashimoto, Hirokazu; Macklin, Wendy B; Wood, Teresa L.
Affiliation
  • Ornelas IM; Department of Pharmacology, Physiology & Neuroscience, New Jersey Medical School, Rutgers University, Newark, New Jersey.
  • Khandker L; Department of Pharmacology, Physiology & Neuroscience, New Jersey Medical School, Rutgers University, Newark, New Jersey.
  • Wahl SE; Department of Pharmacology, Physiology & Neuroscience, New Jersey Medical School, Rutgers University, Newark, New Jersey.
  • Hashimoto H; Department of Cell and Developmental Biology, University of Colorado School of Medicine, Aurora, Colorado.
  • Macklin WB; Department of Cell and Developmental Biology, University of Colorado School of Medicine, Aurora, Colorado.
  • Wood TL; Department of Pharmacology, Physiology & Neuroscience, New Jersey Medical School, Rutgers University, Newark, New Jersey.
Glia ; 68(6): 1274-1290, 2020 06.
Article in En | MEDLINE | ID: mdl-31904150

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Spinal Cord / Cell Differentiation / Oligodendroglia / Bone Morphogenetic Proteins / Sirolimus Limits: Animals Language: En Journal: Glia Journal subject: NEUROLOGIA Year: 2020 Document type: Article Country of publication:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Spinal Cord / Cell Differentiation / Oligodendroglia / Bone Morphogenetic Proteins / Sirolimus Limits: Animals Language: En Journal: Glia Journal subject: NEUROLOGIA Year: 2020 Document type: Article Country of publication: